Cytochromes P450 and metabolism of xenobiotics

Cellular and Molecular Life Sciences

Volumn 58, Issue 5-6, 2001, Pages 737-747

  Anzenbacher, P ^a   Anzenbacherova E ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

CYP; Cytochromes P450; Drug metabolism; Xenobiotic

Indexed keywords

ALFENTANIL; ALPIDEM; ALPRAZOLAM; AMBROXOL; AMITRIPTYLINE; ASTEMIZOLE; ATORVASTATIN; BENZPHETAMINE; BROTIZOLAM; BUDESONIDE; BUPIVACAINE; BUPRENORPHINE; CARBAMAZEPINE; CISAPRIDE; CITALOPRAM; CLARITHROMYCIN; CLOZAPINE; CODEINE; COLCHICINE; CYCLOBENZAPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYCLOSPORIN G; CYTOCHROME P450 1A2; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; CYTOCHROME P450 ISOENZYME; DAPSONE; HYDROCORTISONE; PARACETAMOL; PRASTERONE; UNINDEXED DRUG; XENOBIOTIC AGENT;

DRUG METABOLISM; ENZYME ACTIVE SITE; ENZYME LOCALIZATION; ENZYME STRUCTURE; ENZYME SUBSTRATE; HUMAN; LIVER MICROSOME METABOLISM; NONHUMAN; PHARMACOGENETICS; REVIEW; XENOBIOTIC METABOLISM;

EID: 0034973607     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00000897     Document Type: Review

References (71)

1. P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature
2. P450 gene nomenclature based on evolution
3. Cytochrome P450 and the individuality of species
4. Cytochrome P450
5. Cytochrome P450 2C is an EDRF synthase in coronary arteries
6. Heme-thiolate proteins different from cytochromes P450 catalyzing monooxygenations
7. Towards a unified concept of oxygen activation by heme enzymes: The role of proximal ligand
8. NO synthase is a cytochrome P-450 hemoprotein
9. Structure and function of cytochromes P450: A comparative analysis of three crystal structures
10. Mammalian microsomal cytochrome P450 monooxygenase: Structural adaptations for membrane binding and functional diversity
11. Kinetics of ferric cytochrome P450 reduction by NADPH-cytochrome P450 reductase: Rapid reduction in the absence of substrate and variations among cytochrome P450 systems
12. Evaluation of atypical cytochrome P450 kinetics with two-substrate models: Evidence that multiple substrates can simultaneously bind to cytochrome P450 active sites
13. Molecular modeling of mammalian cytochrome P450s
14. On the recognition of mammalian microsomal cytochrome P450 substrates and their characteristics
15. Flexibility and stability of the structure of cytochromes P450 3A4 and BM-3
16. High conformational stability of cytochrome P450 1A2: Evidence from UV absorption spectra
17. Gene expression in distinct regions of the heart
18. Human cytochrome P450 enzymes
19. Expression of extrahepatic cytochrome P450 in humans
20. In vitro techniques for studying drug metabolism
21. Cytochrome P4503A (CYP3A) metabolism: Prediction of in vivo activity in humans
22. The human drug-metabolizing cytochromes P450
23. Simultaneous assessment of CYP3A4 and CYP1A2 activity in vivo with alprazolam and caffeine
24. Human cytochrome P450 enzymes: A status report summarizing their reactions, substrates, inducers, and inhibitors
25. Regulation of cytochrome P450 (CYP) genes by nuclear receptors
26. Effect of diet and nutrition on the expression of cytochromes P450
27. Age and cytochrome P450-linked drug metabolism in humans: An analysis of 226 humans with equal histopathologic conditions
28. Regulation of cytochromes P450 during inflammation and infection
29. Selective effect of liver disease on the activities of specific metabolizing enzymes: Investigation of cytochromes P450 2C19 and 2D6
30. In vitro and in vivo drug interactions involving human CYP3A
31. Circadian variation of the urinary 6-hydroxycortisol to cortisol ratio that would reflect hepatic CYP3A activity
32. In vitro biotransformation of sildenafil (Viagra): Identification of human cytochromes P450 and potential drug interactions
33. Interaction of cisapride with the human cytochrome P450 system: Metabolism and inhibition studies
34. Contraceptive effectiveness: Cytochromes and induction
35. Cytochrome P-450 3A4: Regulation and role in drug metabolism
36. Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions
37. Effects of the antifungal agents on oxidative drug metabolism
38. Role of cytochrome P450 enzymes in drug-drug interactions
39. Food-drug interactions: Emphasis on grapefruit juice effects
40. Use of homology modeling in conjunction with site-directed mutagenesis for analysis of structure-function relationships of mammalian cytochromes P450
41. Identification of three key residues in substrate recognition site 5 of human cytochrome P450 3A4 by casette and site-directed mutagenesis
42. Elucidation of distinct ligand binding sites for cytochrome P450 3A4
43. Evaluation of the genetic component of variability in CYP3A4 activity: A repeated drug administration method
44. Evidence for a new P-450 hemoprotein in hepatic microsomes from methylcholanthrene treated rats
45. Brassica vegetables increase and apiaceous vegetables decrease cytochrome P450 1A2 activity in humans: Changes in caffeine metabolite ratios in response to controlled vegetable diets
46. Dietary effect on mixed function P450 1A2 activity assayed by estimation of caffeine metabolism in man
47. Role of cytochrome P4501A2 in chemical carcinogenesis: Implications for human variability in expression and enzyme activity
48. Detailed modelling of caffeine metabolism and examination of the CYP1A2 gene: Lack of a polymorphism in CYP1A2 in Caucasians
49. Neonatal lethality associated with respiratory distress in mice lacking cytochrome P450 1A2
50. Properties of cytochrome P450 isoenzymes and their substrates. 2. Properties of cytochrome P450 substrates
51. Genetically determined defects of oxidation at carbon centres of drugs
52. Polymorphic human cytochrome P450 enzymes: An opportunity for individualized drug treatment
53. Use of propafenone metabolic ratio as a measure of CYP2D6 activity
54. The association between polymorphisms in the cytochrome P-450 2D6 gene and Parkinson's disease: A case-control study
55. The CYP2D6 extensive metabolizer genotype is associated with increased risk for bladder cancer
56. Lung cancer and the debrisoquine metabolic phenotype
57. Influence of amino acid residue 374 of cytochrome P450 2D6 (CYP2D6) on the regio- and enantio-selective metabolism of metoprolol
58. CYP2C19 participates in tolbutamide hydroxylation by human liver microsomes
59. The substrate binding site of human liver cytochrome P450 2C9: An NMR study
60. Identification of residues 99, 220 and 221 of human cytochrome P40 2C19 as key determinants of omeprazole hydroxylase activity
61. Respective roles of human cytochrome P-4502E1, 1A2, and 3A4 in the hepatic microsomal ethanol oxidizing system
62. Ethanol-inducible cytochrome P450 (CYP2E1): Biochemistry, molecular biology and clinical relevance. 1996 Update
63. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes
64. Selectivity of cytochrome P4502E1 in chlorzoxazone 6-hydroxylation
65. Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation
66. Post-translational regulation of rat CYP2E1 expression: Role of CYP2E1 mRNA untranslated regions in control of translational efficiency and message stability
67. The growing importance of cytochromes
68. Pharmacogenetics
69. Environmental genome project: Functional analysis of polymorphisms